CINECA IRIS Institutional Research Information System

UGOLINI, CLARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.401
EU - Europa 6.187
AS - Asia 6.077
SA - Sud America 889
AF - Africa 341
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 24.904
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.098
IT - Italia 2.575
SG - Singapore 2.020
CN - Cina 1.582
SE - Svezia 995
HK - Hong Kong 953
DE - Germania 795
BR - Brasile 711
VN - Vietnam 576
GB - Regno Unito 422
BG - Bulgaria 281
FR - Francia 225
TR - Turchia 207
CA - Canada 195
AT - Austria 184
FI - Finlandia 167
RU - Federazione Russa 162
IN - India 161
JP - Giappone 149
CI - Costa d'Avorio 148
NL - Olanda 100
BD - Bangladesh 74
SN - Senegal 68
UA - Ucraina 60
AR - Argentina 54
KR - Corea 51
MX - Messico 50
IQ - Iraq 49
PL - Polonia 43
ZA - Sudafrica 33
ID - Indonesia 32
SA - Arabia Saudita 30
CH - Svizzera 29
BE - Belgio 27
VE - Venezuela 27
ES - Italia 25
PK - Pakistan 25
EC - Ecuador 24
CO - Colombia 19
JO - Giordania 19
NG - Nigeria 19
UZ - Uzbekistan 19
MA - Marocco 17
IR - Iran 16
CL - Cile 15
KE - Kenya 15
LT - Lituania 15
NP - Nepal 13
PH - Filippine 12
PE - Perù 11
PY - Paraguay 11
UY - Uruguay 11
IE - Irlanda 10
JM - Giamaica 10
MY - Malesia 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
HU - Ungheria 9
PT - Portogallo 9
TT - Trinidad e Tobago 9
AZ - Azerbaigian 8
EE - Estonia 8
IL - Israele 8
TN - Tunisia 8
TW - Taiwan 8
DZ - Algeria 7
LB - Libano 7
PA - Panama 7
PS - Palestinian Territory 7
RO - Romania 7
EG - Egitto 6
ET - Etiopia 6
GR - Grecia 6
HN - Honduras 6
BY - Bielorussia 5
DO - Repubblica Dominicana 5
AU - Australia 4
BB - Barbados 4
BO - Bolivia 4
GA - Gabon 4
OM - Oman 4
AM - Armenia 3
BH - Bahrain 3
CR - Costa Rica 3
HR - Croazia 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
BN - Brunei Darussalam 2
BZ - Belize 2
DK - Danimarca 2
GD - Grenada 2
GE - Georgia 2
GH - Ghana 2
GT - Guatemala 2
GY - Guiana 2
KG - Kirghizistan 2
KW - Kuwait 2
MN - Mongolia 2
Totale 24.868
Salva come PNG Salva come JPEG
Città #
Ashburn 1.379
Singapore 1.115
Dallas 1.072
Hong Kong 931
Fairfield 789
San Jose 782
Santa Clara 695
Chandler 630
Woodbridge 601
Houston 452
Ann Arbor 441
Milan 385
Shanghai 355
Seattle 328
Beijing 311
Sofia 279
Wilmington 271
New York 270
Cambridge 254
Los Angeles 220
Boardman 186
Ho Chi Minh City 173
Vienna 162
Princeton 151
Abidjan 148
London 146
Munich 141
Pisa 134
Lawrence 133
Tokyo 126
Florence 125
Ottawa 120
Lauterbourg 118
Rome 118
Hanoi 112
Medford 109
Council Bluffs 100
Izmir 98
Serra 97
Frankfurt am Main 90
Nanjing 72
Columbus 69
Buffalo 68
Dakar 68
Des Moines 67
Naples 67
Istanbul 65
Hefei 64
Redondo Beach 59
São Paulo 58
Bremen 55
San Diego 53
Cascina 49
Jacksonville 49
Turku 48
Orem 47
Seoul 45
Dearborn 43
Helsinki 40
Bologna 39
The Dalles 34
Boulder 32
Ogden 32
Nanchang 29
Chicago 28
Dong Ket 28
Genoa 27
Fuzhou 26
Warsaw 26
Chennai 25
Da Nang 25
Amsterdam 24
Brooklyn 24
Brussels 24
Turin 24
Lancaster 23
Nuremberg 23
Phoenix 23
Vicopisano 23
Atlanta 22
Montreal 22
Stockholm 22
Changsha 21
Denver 20
Düsseldorf 20
Poplar 20
Rio de Janeiro 20
San Francisco 20
Baghdad 19
Bern 19
Lagos 19
Redmond 18
Belo Horizonte 17
Lucca 17
Norwalk 17
Palermo 17
Pune 17
Quanzhou 17
Tashkent 17
Verona 17
Totale 16.170
Salva come PNG Salva come JPEG
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 1.169
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 341
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 275
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 255
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study. 254
HISTIDINE-RICH GLYCOPROTEIN AND HUMAN SKELETAL MUSCLE: POSSIBLE INVOLVEMENT IN MUSCLE CONTRACTION 232
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma 228
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition 227
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 225
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 220
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 217
Thyroid autoimmunity, thyroglobulin autoantibodies and thyroid cancer prognosis 215
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 215
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study 206
Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma 201
The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution 200
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 196
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 195
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 192
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response 190
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases 188
HER2 overexpression as a poor prognostic determinant in resected biliary tract cancer 187
BRAF(K601E) Mutation in a Follicular Thyroid Adenoma 186
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 183
Intrathyroidal differentiated thyroid carcinoma: Tumor size-based surgical concepts 183
Papillary thyroid cancer: Pathological parameters as prognostic factors in different classes of age 183
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up 183
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters 182
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 182
Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma 181
Interest of sentinel node biopsy in apparently intrathyroidal medullary thyroid cancer: a pilot study. 179
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma. 177
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 177
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 177
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. 176
Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy 175
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 175
Role of YAP-1 in Thyroid Tumor Progression and Outcome 174
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion 174
KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease 173
Video assisted prophylactic thyroidectomy and central compartment nodes clearance in two RET gene mutation adult carriers 172
Minimally invasive video-assisted thyroidectomy: an analysis of results and a revision of indications 170
MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis? 170
Tall cell percentage alone in PTC without aggressive features should not guide patients’ clinical management 169
A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma 167
Immune Profiling of Deficient Mismatch Repair Colorectal Cancer Tumor Microenvironment Reveals Different Levels of Immune System Activation 167
Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19 166
Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations 166
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study 165
Lower levels of TSH are associated to a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role 164
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 164
Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas 164
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 164
miRNA expression profiling of ‘noninvasive follicular thyroid neoplasms with papillary-like nuclear features’ compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas 163
Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses 163
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome 162
Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma 162
New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations 161
null 160
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma 160
Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: an ATC-like and a PDTC-like 160
null 159
Identification of targets of twist1 transcription factor in thyroid cancer cells 159
Chronic lithium re-sizes motor neurons and induces neuronogenesis in the spinal cord of a mouse model of amyotrophic lateral sclerosis 157
Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer 157
Metabolomics approach to thyroid nodules: A high-resolution magic-angle spinning nuclear magnetic resonance-based study 155
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases 155
Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center 155
Synchronous Squamous Cell Carcinoma and Papillary Thyroid Carcinoma Arising from the Thyroglossal Duct Remnant: case report and a review of the literature. 154
Extensive clinical experience - Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma 153
EVIDENCE OF A LOW PREVALENCE OF RAS MUTATIONS IN A LARGE MEDULLARY THYROID CANCER SERIES 153
Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration. 153
A microRNA signature for the differential diagnosis of salivary gland tumors 153
Digital Gene Expression Analysis on Cytology Smears Can Rule Out Malignancy in Follicular-Patterned Thyroid Tumors 153
Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior 152
Fenotipo misto MEN2A/MEN2B da nuova mutazione germinale di RET: prima descrizione clinico-genetica e iconografia 152
null 150
COVID-19 autopsy cases: detection of virus in endocrine tissues 150
Role of frozen section associated with intraoperative cytology in comparison to FNA and FS alone in the management of thyroid nodules 148
Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin. 147
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis 147
Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer 146
Human α-L-fucosidase-1 attenuates the invasive properties of thyroid cancer 145
Correlation Between The Presence Of Macrophages And Braf V600e Mutation In Different Variants Of Well Differentiated Papillary Thyroid Cancer 144
A dual mechanism of activation of the sonic hedgehog pathway in anaplastic thyroid cancer: Crosstalk with RAS-BRAF-MEK pathway and ligand secretion by tumor stroma 144
Effects of proton pump inhibitors on healing of gastric ulcerations induced by a continued non steroidal anti-inflammatory drug (NSAID) treatment 143
Differences in miRNA expression profiles between wild-type and mutated NIFTPs 143
The management of colorectal liver metastases amenable of surgical resection: How to shape treatment strategies according to clinical, radiological, pathological and molecular features 143
Toward the Reliable Diagnosis of Indeterminate Thyroid Lesions: A HRMAS NMR-Based Metabolomics Case of Study 141
Mast cells have a protumorigenic role in human thyroid cancer 140
Thyroid papillary carcinoma: preliminary evidence for a germ-line single nucleotide polymorphism in the Fas gene 139
L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients 137
BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features. 137
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma 137
Dynamic profiling of the immune tumor microenvironment in locally advanced gastric cancer treated with perioperative chemotherapy 135
Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens 135
Functional Characterization of the Novel T599I-VKSRdel BRAF Mutation in a Follicular Variant Papillary Thyroid Carcinoma 131
TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells 131
Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study 129
Sarcina Ventriculi infection: a rare but fearsome event. A Systematic Review of the Literature 129
Totale 18.198
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.371
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.607 47 38 56 109 302 236 62 74 76 72 122 413
2022/20232.640 331 408 187 195 250 289 58 190 441 46 193 52
2023/20241.999 185 168 187 202 246 285 158 86 78 89 125 190
2024/20255.745 134 228 97 331 556 556 463 276 605 680 575 1.244
2025/20267.637 471 882 958 627 733 587 1.184 363 464 739 325 304
2026/202746 46 0 0 0 0 0 0 0 0 0 0 0
Totale 25.310